Chronic inflammation is a molecular element of the metabolic syndrome and type 2 diabetes. Saturated fatty acids (SFAs) are considered to be an important proinflammatory factor. However, it is still incompletely understood how SFAs induce proinflammatory cytokine expression. Hereby we report that activating transcription factor 4 (ATF4), a transcription factor that is induced downstream of metabolic stresses including endoplasmic reticulum (ER) stress, plays critical roles in SFA-induced interleukin-6 (Il6) expression. DNA microarray analysis using primary macrophages revealed that the ATF4 pathway is activated by SFAs. Haploinsufficiency and shRNA-based knockdown of ATF4 in macrophages markedly inhibited SFA-and metabolic stresses-induced Il6 expression. Conversely, pharmacological activation of the ATF4 pathway and overexpression of ATF4 resulted in enhanced Il6 expression. Moreover, ATF4 acts in synergy with the Toll-like receptor-4 signaling pathway, which is known to be activated by SFAs. At a molecular level, we found that ATF4 exerts its proinflammatory effects through at least two different mechanisms; ATF4 is involved in SFA-induced nuclear factor-κB activation and ATF4 directly activates the Il6 promoter. These findings provide evidence suggesting that ATF4 links metabolic stress and Il6 expression in macrophages.
INTRODUCTION
Chronic inflammation is a molecular element of the metabolic syndrome and type 2 diabetes. Several proinflammatory signaling pathways, including the interleukin-6 (IL6) signaling, are shown to play essential roles in the pathophysiology of the metabolic syndrome, type 2 diabetes, and subsequent cardiovascular diseases (1) (2) (3) . As a causative factor of chronic inflammation, several lines of evidence support the role of free fatty acids. Of note, saturated fatty acids (SFAs), such as palmitate and stearate, have been shown to induce proinflammatory cytokine production in various cell types including macrophages (4, 5) .
However, the underlying mechanism of SFA-induced proinflammatory cytokine expression is only partially elucidated.
To date, we and others have demonstrated that Toll-like receptor-4 (TLR4), a pathogen sensor expressed on the cell surface, plays a critical role in the SFA-induced proinflammatory cytokine expression (4) (5) (6) . On the other hand, multiple mechanisms are involved in the SFA-induced cellular responses (1, (7) (8) . Among them, attention has been focused on the role of cellular metabolic stresses such as endoplasmic reticulum (ER) stress and oxidative stress (1) . Recent reports suggest that modulation of metabolic stress pathways may alter high-fat diet-induced proinflammatory cytokine expression as well as insulin resistance (9, 10).
Therefore, it is of importance to clarify the molecular mechanism by which metabolic stresses affect proinflammatory cytokine expression.
In this study, using DNA microarray and network analyses in macrophages, we show that activating transcription factor 4 (ATF4), a basic leucine zipper transcription factor, is potently induced by SFAs. We provide evidence that ATF4 plays essential roles in Il6 expression induced by various metabolic stresses including ER stress. Furthermore, the ATF4 pathway has a synergistic effect on the TLR4 signaling pathway, enhancing Il6 expression. As the molecular mechanisms, ATF4 is capable of enhancing metabolic stress-induced nuclear Invitrogen) according to the manufacturer's protocol. Retrovirus-mediated knockdown of ATF4 was performed as previously described (18). The target sequences for shATF4 were 5'-TCCCTCCATGTGTAAAGGA-3' (shATF4 #1) and 5'-CTCTGTTTCGAATGGATGA-3' (shATF4 #2), respectively. As a negative control, shGFP was used as described previously (18).
Luciferase assay.
For the ATF4-5'UTR luciferase assay, RAW264 macrophages seeded on 24-well plates were transiently cotransfected with 30 ng renilla and 600 ng firefly luciferase reporter plasmids.
For the Il6 promoter luciferase assay, RAW264 macrophages were transiently cotransfected with 50 ng renilla and 250 ng firefly luciferase reporter plasmids. After 24 h following transfection, cells were collected and luciferase activity was measured with a dual-luciferase reporter assay system (Promega) according to the manufacturer's protocol. All data were normalized for transfection efficiency by the division of firefly luciferase activity by renilla luciferase activity.
NF-κ κ κ
κB RelA DNA-binding activity assay.
Ten micrograms of nuclear extracts was used to determine RelA (p65) DNA-binding activity using an ELISA-based assay (Active Motif TransAM #40096, CA, USA), according to the manufacturer's instructions. In brief, κB oligonucleotide-coated plates (in a 96-well format)
were incubated for 1 h with the nuclear extracts. Specificity was achieved by incubation with anti-RelA primary antibodies for 1 h. HRP-conjugated secondary antibodies were used for the detection of RelA bound to the κB sequences.
Enzyme-linked immunosorbent assay.
ELISA of mouse IL6 was performed using Mouse IL6 Quantikine ELISA Kit (R&D Systems,
RESULTS AND DISCUSSION
The ATF4 pathway is activated by SFAs in the absence of TLR4
In an attempt to identify novel mechanisms underlying the SFA-induced inflammatory responses, we performed DNA microarray analysis of palmitate-stimulated peritoneal macrophages obtained from Tlr4-deficient and wild-type mice. A total of 122 genes were upregulated by palmitate in both Tlr4-deficient and wild-type macrophages (Fig. 1a) . We next performed Markov clustering of these genes using STRING database (20), which produced several clusters (Fig. 1b) . Pathway analysis using Reactome database (21) identified two large clusters in which target genes for ATF4 and NF-κB were enriched (Fig. 1c) . Indeed, several signaling pathways that can induce ATF4 were significantly enriched in gene ontology analysis (Fig. S1 ).
ATF4 is induced following phosphorylation of eukaryotic initiation factor-2α (eIF2α), which is mediated by eIF2α kinases (i.e., HRI, PKR, PERK, and GCN2) under metabolic stresses such as ER stress, oxidative stress, and amino acid deprivation (22). Previous reports showed that at least two of the eIF2α kinases, PKR and PERK, are activated by SFAs (9, 23).
Consistently, pharmacological inhibitors of PKR and PERK suppressed palmitate-induced activation of the ATF4 pathway (Fig. S2a, b) , suggesting that PKR and PERK are likely to be involved in SFA-induced eIF2α phosphorylation. When eIF2α is phosphorylated, ATF4
translation is preferentially upregulated through the characteristic upstream open reading frames in the 5'-untranslated region (5'-UTR) (24). Using ATF4-5'-UTR-luciferase assay, we confirmed that ATF4 translation was activated by palmitate in RAW264 macrophage-like cell lines (Fig. 1d ). In line with this, palmitate increased ATF4 protein levels and the expression of target genes, such as tribbles homologue-3 (Trib3) and c/ebp homologous protein, (Chop, also known as Ddit3) (25), in peritoneal macrophages, at least in part, independent of TLR4 ( Fig. 1e, S2d). We also observed that other branches of the unfolded protein response were activated by palmitate in the absence of TLR4 (Fig. S2c, d ). Intriguingly, we found that, even in Tlr4-deficient macrophages, palmitate increased the expression of some proinflammatory cytokines, such as Il6 and Tnf, to a lesser extent than wild-type (Fig. S2d) . Consistent with this, nuclear protein levels and activity of RelA (p65), a transcriptional activating subunit of NF-κB, were increased by palmitate in both wild-type and Tlr4-deficient macrophages (Fig.   1e, f) . These results suggest that the ATF4 pathway, as well as the NF-κB pathway, is activated in macrophages by palmitate in the absence of TLR4.
In addition, we confirmed that stearate, another SFA, also activated the ATF4 pathway in RAW264 macrophages (Fig. S3a) . By contrast, unsaturated fatty acids (UFAs) such as oleate and eicosapentaenoic acid (EPA) did not activate the ATF4 pathway (Fig. S3b) . Notably, EPA effectively suppressed palmitate-induced activation of the ATF4 pathway (Fig. S3b) . We also found that pharmacological inhibition of fatty acid desaturation resulted in upregulation of ATF4 target genes ( 
ATF4 is required for Il6 expression in response to metabolic stresses
In contrast to NF-κB (30), the role of ATF4 in the inflammatory pathway is not yet fully characterized. Because Atf4 null mice are mostly embryonic or neonatal lethal (31), in this study, we used primary macrophages obtained from Atf4-haploinsufficient mice. We found that bone marrow-derived macrophages from Atf4-haploinsufficient mice were defective in palmitate-induced mRNA expression of Il6 (Fig. 2a) . Tnf expression was only marginally attenuated in Atf4-haploinsufficient macrophages. Consistently, Atf4-haploinsufficient macrophages showed decreased secretion of IL6 in the media (Fig. 2b) . Similarly, Atf4-haploinsufficient peritoneal macrophages showed attenuated Il6 expression induced by ER stressors, such as tunicamycin (Fig. 2c, d ) and thapsigargin (Fig. 2e ), compared to wild-type macrophages. To test the importance of ATF4 in RAW264 macrophages, we knocked down Atf4, which was confirmed by quantitative PCR and Western blotting (Fig. S4a,   b ). Atf4 knockdown (KD) reduced SFAs- (Fig. S4c) or ER stress- (Fig. S4d) induced Il6 expression. On the other hand, in macrophages without treated with these stressors, there was no significant difference in lipid A (a bona fide TLR4 ligand)-induced proinflammatory cytokine expression between the genotypes (Fig. 2f) . To test the in vivo functional role of ATF4, we activated the ATF4 pathway by intraperitoneal injection of tunicamycin (Fig. 2g ).
Sixteen hours after the injection, tunicamycin treatment potently induced Atf4 and Il6 mRNA expression in the spleen and liver from wild-type mice, which was significantly decreased in those from Atf4-haploinsufficient mice. Tnf expression was not significantly decreased. We obtained a similar result using purified CD11b positive splenic macrophages (Fig. S5) . In this study, we observed no apparent difference in LPS-induced Il6 mRNA expression between the genotypes (data not shown). These observations suggest that ATF4 plays a critical role in the metabolic stress-induced proinflammatory cytokine expression in vitro and in vivo.
The ATF4 pathway enhances Il6 expression in synergy with the TLR4 pathway
We next examined the impact of the ATF4 pathway activation on proinflammatory cytokine expression in cells under metabolic stresses. Pretreatment of various macrophages with ER stressors markedly enhanced the lipid A-induced mRNA expression and secretion of IL6 ( Fig. 3a-c, S6a ). The expression levels of Tnf were also affected to a lesser extent (Fig. 3a, b). Similar results were obtained using murine embryonic fibroblasts (MEFs) (Fig. S6c) .
Although the magnitude varied, the patterns of gene expression in response to ER stressors and TLR4 agonists were similar among cell types. Notably, this enhancement was significantly attenuated in Atf4-haploinsufficient macrophages (Fig. 3d ), ATF4-KD RAW264 macrophages (Fig. S6b) , and Atf4-deficient MEFs (Fig. S6c ). These observations suggest that the ATF4 pathway has a synergistic effect on the TLR4 signaling pathway.
In addition to the eIF2α-ATF4 branch, ER stress activates two other branches of the unfolded protein response; the inositol requiring enzyme 1α-X-box binding protein 1 (XBP1) and ATF6 branches, the former of which is also involved in proinflammatory cytokine expression (32). To specifically stimulate the ATF4 pathway, we employed saluburinal, an inhibitor of eIF2α phosphatase complex (33). Pretreatment of bone marrow-derived macrophages with salubrinal resulted in upregulation of ATF4 ( Fig. 3e ) and its target genes, whereas its effect on XBP1 splicing was minimal ( pathway is also involved in the regulation of metabolic stress-induced proinflammatory cytokine expression. Of note, a recent report showed that the ATF4 pathway was attenuated following the low-dose treatment of TLR4 ligands in cultured macrophages (34). Collectively, it is conceivable that there is a bidirectional crosstalk between the ATF4 and TLR4 pathways.
ATF4 is involved in NF-κB activation in response to metabolic stresses
We next aimed to clarify the molecular mechanism of the SFA-induced Il6 expression through the ATF4 pathway. First, we examined the effect of ATF4 on palmitate-induced NF-κB activation, since our microarray analysis revealed that the NF-κB pathway was activated in Tlr4-deficient macrophages (Fig. 1b, c) . In this study, we found that the nuclear protein levels and activity of RelA were increased by palmitate even in the absence of TLR4
( Fig. 1e, f) . Interestingly, Atf4 haploinsufficiency markedly reduced nuclear protein levels of RelA induced by palmitate or thapsigargin in peritoneal macrophages (Fig. 4a, b) . We next examined the kinetics of cytoplasmic IκBα degradation, a well-recognized event prior to nuclear translocation of RelA (30), and found no apparent difference in cytoplasmic IκBα protein levels between the genotypes (Fig. 4c) . Moreover, we observed that nuclear NF-κB activity induced by palmitate was significantly attenuated in Atf4-haploinsufficient macrophages relative to wild-type macrophages (Fig. 4d ). Consistently, a chromatin immunoprecipitation (ChIP) assay showed decreased recruitment of RelA to the Il6 promoter region in Atf4-haploinsufficient macrophages (Fig. 4e ). Since the transcriptional activity of RelA can be regulated by multiple mechanisms (30), further studies are required to elucidate how ATF4 affects RelA activity. Although a previous report showed that phosphorylation of eIF2α leads to NF-κB activation in MEFs (35), our data provide novel evidence that ATF4 is involved in metabolic stress-induced NF-κB activation in macrophages.
ATF4 directly activates the Il6 promoter.
On the basis of its potent proinflammatory effect, we next examined whether ATF4 directly activates Il6 transcription. The consensus binding sequence of ATF4 is identical to the cyclic AMP response element (CRE) (36). The Il6 promoter contains an evolutionarily conserved region in which a putative ATF4 binding sequence is located in the vicinity of the NF-κB binding site (Fig. 5a) . We, therefore, performed the Il6 promoter luciferase assay using RAW264 macrophages. The luciferase activity was increased by treatment with LPS, which was further enhanced by ATF4 overexpression (Fig. 5b) . The effect of ATF4 overexpression was abolished when transfected with the promoter construct containing a mutant CRE.
Interestingly, the mutation in the CRE also markedly inhibited the LPS-induced activation of the Il6 promoter. Consistently, experiments with a series of truncated Il6 promoter constructs showed marked reduction of the promoter activity in the absence of CRE (Fig. S5) ,
suggesting that the CRE is indispensable for the LPS-and ATF4-induced activation of the Il6 promoter. To confirm the direct recruitment of ATF4 to the Il6 promoter region, we performed a ChIP assay using peritoneal macrophages. Signals from the promoter region containing the CRE were significantly increased upon treatment with palmitate or thapsigargin plus lipid A (Fig. 5c ). These data suggest that ATF4 directly activates the Il6 promoter.
In this study, we demonstrated that ATF4 is induced downstream of metabolic stresses caused by SFAs and ER stressors. ATF4 exerts its proinflammatory effects through at least two different mechanisms; direct activation of the Il6 promoter and involvement in NF-κB activation (Fig. 5d ). According to previous reports, other members of ATF/CREB family of transcription factors are also involved in positive (e.g., XBP1) or negative (e.g., ATF3) regulation of Il6 expression (18, 32). Of note, these factors may be induced downstream of TLR4 stimulation even independent of ER stress (18, 32). By contrast, our results suggest that ATF4 is minimally involved in the TLR4 signaling in unstressed cells. Considering that the ATF4 pathway is activated under a variety of metabolic stresses, ATF4 would constitute a critical link between metabolic stresses and Il6 expression.
Furthermore, our observations that the ATF4 pathway acts in synergy with the TLR4 pathway raise a possibility that metabolic stresses affect innate immune response. Consistent with several previous reports (4-6), our results suggest that TLR4 is required for proinflammatory effects of SFAs. Importantly, the current study also identifies the ATF4 pathway as a novel mechanism of SFA-induced proinflammatory cytokine expression that is induced even in the absence of TLR4. Given that SFAs activate both TLR4 and various metabolic stress pathways upstream of ATF4 (1, (4) (5) (6) (7) (8) (9) , the crosstalk between these pathways would be important for better understanding of the molecular mechanism of SFA-induced proinflammatory cytokine expression. Collectively, our findings raise the possibility that ATF4 plays a role in the pathophysiology of chronic inflammation in the metabolic syndrome and type 2 diabetes. Expression levels of proinflammatory cytokines at the indicated time points (* P < 0.05, ** P < 0.01, n = 3). d) IL6 levels in the culture media obtained from 24 h treated samples (** P = 0.0006, n = 3). e-f) Expression levels of proinflammatory cytokines were measured at the indicated time points. e) Atf4+/+ and Atf4+/-peritoneal macrophages were treated with 1 µM thapsigargin (** P < 0.01, n = 3). f) Atf4+/+ and Atf4+/-peritoneal macrophages were treated with 10 ng/ml lipid A (n = 3). g) Atf4+/+ and Atf4+/-mice were intraperitoneally injected with tunicamycin (Tu) 1mg/kg or DMSO (Veh). Sixteen h after injection, expression levels of Atf4 and proinflammatory cytokines were examined in the spleen and the liver (* P < 0.05, n = 5). for 24 h (* P < 0.05, ** P < 0.01, *** P < 0.001, n = 3). Expression levels of proinflammatory cytokines and Xbp1s were measured (* P < 0.05, ** P < 0.01, n = 4). d) Control (shGFP) and ATF4-knockdown (shATF4) RAW264 macrophages were treated with 1 µM thapsigargin. Expression levels of Il6 were measured at the indicated time points (** P < 0.01, *** P < 0.001, n = 3).
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Supplementary figure 5. Atf4 haploinsufficiency attenuates ER stress-induced Il6
expression in splenic macrophages.
Atf4+/+ (n = 6) and Atf4+/-(n = 5) mice were intraperitoneally injected with tunicamycin (Tu) 1 mg/kg or DMSO (Veh). Sixteen h after injection, mice were sacrificed, and splenic CD11b-positive (CD11b (+)) and negative (CD11b (-)) cells were purified using anti-CD11b magnetic beads. a) Expression levels of representative macrophage markers in CD11b (+) and CD11b (-) populations were analyzed (*** P < 0.001). b) Expression levels of Atf4 , Trib3 and Il6 were analyzed (* P < 0.05). proinflammatory cytokines were measured (* P < 0.05, ** P < 0.01, *** P < 0.001, n = 3). e) RAW264 macrophages were pretreated with 50 µM salubrinal (Sal) or DMSO (Veh) for 4 h, then stimulated with 10 ng/ml lipid A for 4 h. Levels of IL6 in culture media were measured (** P < 0.01, n = 3). f) RAW264 cell lines were pretreated for 2 h with azetidine (AZC, 1 mM and 2 mM) or PBS (veh), then stimulated with 10 ng/ml lipid A for 4 h. Expression levels of the ATF4 pathway and proinflammatory cytokines were measured (** P < 0.01, *** P < 0.001, n = 3). 
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